Cocaine-Related Disorders: all 419 studies

Page 4 of 5. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.

• Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent IndividualsCompletedNCT00217997
• Effectiveness and Costs of Enhanced Cocaine TreatmentsCompletedNCT00167258Phase 2
• Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol DependenceCompletedNCT00167232Phase 3
• The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1CompletedNCT00158288Phase 2
• Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2CompletedNCT00158132Phase 2
• The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3TerminatedNCT00142883Not applicable
• Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1CompletedNCT00142844Phase 2
• Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid AddictsCompletedNCT00142779Not applicable
• Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1CompletedNCT00136825Phase 1
• Methylphenidate Treatment for Cocaine Abuse and ADHD - 1CompletedNCT00136734Phase 1
• Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1CompletedNCT00129298Phase 2
• Cocaethylene as a Treatment for Cocaine Dependence - 1CompletedNCT00124696Phase 1
• Randomised Placebo-Controlled Trial of Modafinil for Cocaine DependenceStatus unknownNCT00123383Phase 2
• Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1Status unknownNCT00100113Phase 1
• Modafinil for the Treatment of Cocaine Dependence - 1CompletedNCT00100100Phase 2
• Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1Status unknownNCT00094315Phase 1
• Interactions Between Cocaine and Ethanol and Disulfiram - 1Status unknownNCT00094289Phase 1
• GBR 12909 Study in Cocaine Experienced African American Volunteers - 1Status unknownNCT00089687Phase 1
• Interaction Between Cocaine and Quetiapine - 1Status unknownNCT00087750Phase 1
• Tiagabine for the Treatment of Cocaine Dependence - 1CompletedNCT00086255Phase 2
• Baclofen for the Treatment of Cocaine Dependence - 1CompletedNCT00082485Phase 2
• Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1CompletedNCT00067535Phase 1
• Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1CompletedNCT00061087Phase 2/3
• Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1Status unknownNCT00051896Phase 1
• Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1Status unknownNCT00040066Phase 1
• A Study of Cabergoline for the Treatment of Cocaine Dependence - 1CompletedNCT00033111Phase 2
• Cocaine-Metyrapone Interaction Study - 1Status unknownNCT00033098Phase 1
• Ondansetron for the Treatment of Cocaine Dependence - 1CompletedNCT00033085Phase 2
• Assessment of Potential Interactions Between Cocaine and Tolcapone - 1Status unknownNCT00033059Phase 1
• Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1Status unknownNCT00033046Phase 1
• Reserpine for the Treatment of Cocaine Dependence - 1CompletedNCT00033033Phase 2
• Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1CompletedNCT00032929Phase 3
• Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1Status unknownNCT00032916Phase 1
• Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11CompletedNCT00015301Phase 4
• Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9CompletedNCT00015275Phase 4
• Prepulse Inhibition of Startle in Cocaine Dependence - 7CompletedNCT00015249Phase 1
• Modeling Impaired Judgement in Cocaine Abusers - 6CompletedNCT00015236Phase 4
• Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5CompletedNCT00015223Phase 2
• Nefazodone in the Treatment of Cocaine Dependence and Depression - 4CompletedNCT00015210Phase 2
• Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9CompletedNCT00015132Phase 2
• Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7CompletedNCT00015106Phase 2
• Naltrexone in Treatment of Cocaine Dependence - 5CompletedNCT00015080Phase 2
• Cocaine-Methylphendidate Interaction Study - 4CompletedNCT00015067Phase 1
• Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3CompletedNCT00015054Phase 2
• Infusion Laboratory: Protocol 5 (Flupenthixol) - 14Status unknownNCT00000349Phase 1
• Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13Status unknownNCT00000348Phase 1
• Risperidone for Treatment of Cocaine Dependence in Outpatients - 12CompletedNCT00000347Phase 2
• Risperidone for the Treatment of Cocaine Dependence - 7CompletedNCT00000342Phase 2
• Pemoline in the Treatment of Stimulant Dependence - 5WithdrawnNCT00000340Phase 2
• Infusion Laboratory: Protocol 3 (Risperidone) - 4Status unknownNCT00000339Phase 1
• Infusion Laboratory: Protocol 2 (Lisuride) - 3Status unknownNCT00000338Phase 1
• Infusion Laboratory: Protocol 1 - Selegeline - 2CompletedNCT00000337Phase 1
• Selegiline in Outpatient Treatment for Cocaine Dependence - 1CompletedNCT00000336Phase 2
• Evaluation of Benztropine for Cocaine Craving - 2CompletedNCT00000333Phase 2
• High Dose Nimodipine Treatment Adjunct - 1CompletedNCT00000332Phase 2
• Psychostimulant Abuse - Novel Treatment Approaches - 1CompletedNCT00000325Phase 1
• Tryptophan and Behavior Therapy for Cocaine Abuse - 1CompletedNCT00000324Phase 2
• Therapeutic Potential of Kappa-Opioids Against Cocaine - 1CompletedNCT00000323
• Early Phase II Trials for Cocaine Medication Development - 1CompletedNCT00000317Phase 2
• Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2CompletedNCT00000316Phase 1
• Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1CompletedNCT00000315Phase 1
• M-CPP and Fenfluramine in Cocaine Addicts - 3CompletedNCT00000314Phase 2
• Predictive Values of Serotonergic Alterations for Outcome - 2TerminatedNCT00000313Phase 1
• Alterations in Serotonergic Functions in Cocaine Addicts - 1CompletedNCT00000312Phase 1
• Combining Behavioral Treatment With Agonist Maintenance - 1CompletedNCT00000311Phase 3
• Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2TerminatedNCT00000310Phase 2
• Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1TerminatedNCT00000309Phase 2
• Dextroamphetamine-Cocaine Behavioral Intervention - 5CompletedNCT00000308Phase 2
• Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4CompletedNCT00000307Phase 2
• Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3CompletedNCT00000306Phase 2
• Amphetamine Cocaine Interaction Study - 2TerminatedNCT00000305Phase 1
• Dextroamphetamine as an Adjunct in Cocaine Treatment - 1CompletedNCT00000304Phase 2
• Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6CompletedNCT00000303Phase 2
• Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4CompletedNCT00000301Phase 2
• Effects of Carvedilol on Cocaine Use in Humans - 11CompletedNCT00000294Phase 2
• Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10CompletedNCT00000293Phase 3
• Acute Withdrawal From Smoked Cocaine - 9CompletedNCT00000292Phase 1
• Effects of Labetalol on Human Cocaine Use - 8CompletedNCT00000291Phase 2
• Stress Hormones and Human Cocaine Use - 7CompletedNCT00000290Phase 1
• Relapse Patterns in Female Cocaine Users - 4CompletedNCT00000287
• Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3CompletedNCT00000286Phase 2
• Effects of Phenytoin on Cocaine Use in Humans - 2CompletedNCT00000285Phase 1
• Pemoline for Cocaine Abuse - 7CompletedNCT00000282Phase 2
• Pharmacotherapy for Schizophrenic Drug Users - 6CompletedNCT00000281Phase 2
• Glutaminergic Agents for Cocaine Abuse - 5CompletedNCT00000280Phase 1
• Disulfiram for Cocaine-Alcohol Abuse - 3CompletedNCT00000278Phase 2
• Mazindol for Cocaine Abuse - 2CompletedNCT00000277Phase 2
• Dopamine Reuptake Inhibitors of Cocaine Abuse - 1TerminatedNCT00000276Phase 1
• Cocaine Abuse and ADHD - 10CompletedNCT00000275Phase 2
• Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9CompletedNCT00000274Phase 2
• New Approaches to Cocaine Abuse Medications (A) - 6CompletedNCT00000271Phase 2
• Brain Imaging: Cocaine Effects & Medication Development - 5WithdrawnNCT00000270Phase 4
• Pergolide Treatment for Substance Abusers - 4CompletedNCT00000269Phase 2
• Cocaine Abuse and Attention Deficit Disorder - 3CompletedNCT00000268Not applicable
• Risperidone Treatment in Dually-Diagnosed Individuals - 2CompletedNCT00000267Phase 2
• Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1CompletedNCT00000266Phase 2
• Dose Response Trial of Pergolide for Cocaine Dependence - 1CompletedNCT00000248Phase 3
• Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1CompletedNCT00000245Phase 2
• Carbamazepine Treatment of Cocaine Dependence - 1CompletedNCT00000242Phase 2
• Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22CompletedNCT00000240Phase 2

← Cocaine-Related Disorders overview